150 related articles for article (PubMed ID: 14705988)
1. A new HLA-B44 allele (B*44020102S) with a splicing mutation leading to a complete deletion of exon 5.
Dubois V; Tiercy JM; Labonne MP; Dormoy A; Gebuhrer L
Tissue Antigens; 2004 Feb; 63(2):173-80. PubMed ID: 14705988
[TBL] [Abstract][Full Text] [Related]
2. Sequence of a new class I null allele within the HLA-B44 specificity.
Bettens F; Tiercy JM
Tissue Antigens; 2000 Nov; 56(5):441-5. PubMed ID: 11144292
[TBL] [Abstract][Full Text] [Related]
3. A new HLA-B44 variant (B44BO [B*4408]) identified by serology.
Darke C; Street J; Fussell H; Thomas M; Guttridge M; Goldberg TE; Arnett KL; Parham P
Tissue Antigens; 1997 Jul; 50(1):32-7. PubMed ID: 9243752
[TBL] [Abstract][Full Text] [Related]
4. Identification of two major HLA-B44 subtypes and a novel B44 sequence (B*4404). Oligotyping and solid phase sequencing of polymerase chain reaction products.
Yao Z; Keller E; Scholz S; McNicholas A; Volgger A; Albert ED
Hum Immunol; 1995 Jan; 42(1):54-60. PubMed ID: 7751160
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HLA-B*44 alleles encoded on extended HLA haplotypes by direct automated sequencing.
Petersdorf EW; Setoda T; Smith AG; Hansen JA
Tissue Antigens; 1994 Oct; 44(4):211-6. PubMed ID: 7871521
[TBL] [Abstract][Full Text] [Related]
6. Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele.
Curran MD; Williams F; Little AM; Rima BK; Madrigal JA; Middleton D
Tissue Antigens; 1999 Mar; 53(3):244-52. PubMed ID: 10203017
[TBL] [Abstract][Full Text] [Related]
7. A novel HLA-B*44 allele, HLA-B*4459, identified in a renal patient with aberrant B44 serology and characterized by sequence-based typing.
Hammond L; Dunn PP
Tissue Antigens; 2008 Nov; 72(5):494-5. PubMed ID: 18764811
[TBL] [Abstract][Full Text] [Related]
8. A new HLA-C allele, Cw*1403, associated with HLA-B44 in Japanese.
Wang H; Tokunaga K; Ishikawa Y; Lin L; Kashiwase K; Nakajima F; Ogawa A; Kuwata S; Akaza T; Tadokoro K
Hum Immunol; 1995 Aug; 43(4):295-300. PubMed ID: 7499177
[TBL] [Abstract][Full Text] [Related]
9. A "silent" nucleotide substitution in exon 4 is responsible for the "alternative expression" of HLA-A*01:01:38L through aberrant splicing.
Dunn PP; Hammond L; Coates E; Street J; Griner L; Darke C
Hum Immunol; 2011 Sep; 72(9):717-22. PubMed ID: 21741421
[TBL] [Abstract][Full Text] [Related]
10. HLA-B*4431: a new HLA-B variant with a complex ancestral history involving HLA-B*44, B*40 and B*07 alleles.
Przemeck M; Elsner HA; Sel S; Pastucha LT; Blasczyk R
Tissue Antigens; 2002 Jul; 60(1):91-4. PubMed ID: 12366789
[TBL] [Abstract][Full Text] [Related]
11. Identification of HLA-B44 subtypes associated with extended MHC haplotypes.
Kruskall MS; Eynon EE; Awdeh Z; Alper CA; Yunis EJ
Immunogenetics; 1987; 26(4-5):216-9. PubMed ID: 3653939
[TBL] [Abstract][Full Text] [Related]
12. Identification of the novel allele B*4427 and a confirmatory sequence (B*44022).
Canossi A; Papola F; Liberatore G; Del Beato T; Piancatelli D; Tessitore A; Vicentini MT; Maccarone D; Aureli A; Cervelli C; Di Rocco M; Casciani CU; Adorno D
Tissue Antigens; 2002 Apr; 59(4):331-4. PubMed ID: 12135436
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetics of a new HLA-B null allele, HLA-B*4423N.
Hammond L; Street J; Downing J; Thompson J; Darke C
Eur J Immunogenet; 2003 Dec; 30(6):385-6. PubMed ID: 14675390
[TBL] [Abstract][Full Text] [Related]
14. A single amino acid exchange shifts the serological reactivity of the novel HLA-B*4442 allele product from HLA-B44 to HLA-B21.
Mrazek F; Fae I; Ambruzova Z; Raida L; Kriegova E; Indrak K; Fischer GF; Petrek M
Int J Immunogenet; 2006 Jun; 33(3):197-200. PubMed ID: 16712651
[TBL] [Abstract][Full Text] [Related]
15. A mutated HLA-A*0101 allele in the colorectal cell line HCA-7.
Bicknell DC; Bodmer WF
Tissue Antigens; 2005 Sep; 66(3):231-7. PubMed ID: 16101834
[TBL] [Abstract][Full Text] [Related]
16. High-resolution histocompatibility testing of a group of sixteen B44-positive, ABDR serologically matched unrelated donor-recipient pairs. Analysis of serologically undisclosed incompatibilities by cellular techniques, isoelectrofocusing, and HLA oligotyping.
Rufer N; Breur-Vriesendorp BS; Tiercy JM; Slavcev AS; Lardy NM; Francis P; Kressig R; Speiser DE; Helg C; Chapuis B
Hum Immunol; 1993 Nov; 38(3):235-9. PubMed ID: 8106284
[TBL] [Abstract][Full Text] [Related]
17. Sequence, genetics and serology of a new HLA-B allele: B*4903.
Darke C; Street J; Guttridge MG
Tissue Antigens; 2001 May; 57(5):478-80. PubMed ID: 11556975
[TBL] [Abstract][Full Text] [Related]
18. Sequencing of two HLA-A blank alleles: implications in unrelated bone marrow donor matching.
Zanone-Ramseier R; Gratwohl A; Gmür J; Roosnek E; Tiercy JM
Transplantation; 1999 May; 67(10):1336-41. PubMed ID: 10360587
[TBL] [Abstract][Full Text] [Related]
19. An intronic mutation responsible for a low level of expression of an HLA-A*24 allele.
Laforet M; Froelich N; Parissiadis A; Bausinger H; Pfeiffer B; Tongio MM
Tissue Antigens; 1997 Oct; 50(4):340-6. PubMed ID: 9349616
[TBL] [Abstract][Full Text] [Related]
20. HLA-B44 subtypes and the chance of finding HLA compatible donor/recipient pairs for bone marrow transplantation: a haplotype study of 303 Italian families.
Mattiuz PL; Di Paolo E; Fossombroni V; Menicucci A; Pradella F; Porfirio B; Rombolà G
Tissue Antigens; 1997 Dec; 50(6):602-9. PubMed ID: 9458113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
